CClinicalTrials.gg
Status unknownNCT02917590Updated Sep 28, 2016

Dual-task Obstacle Crossing Training in Ambulatory Subjects With Spinal Cord Injury

An interventional study of Dual-task obstacle crossing training and Single-task obstacle crossing training in Injuries, Spinal Cord, sponsored by Khon Kaen University. Status unknown. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2016-09-28.

Sponsored by Khon Kaen University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2016), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
7
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Is dual-task obstacle crossing training more efficiently than single-task obstacle crossing training on the improvement of walking ability, balance ability, and lower extremity muscle strength in ambulatory subjects with spinal cord injury

Read the detailed description

To compare immediate effects of dual-task and single-task obstacle crossing training in ambulatory subjects with spinal cord injury

02

Conditions studied

  • Injuries, Spinal Cord

Keywords

  • Spinal cord injury
  • dual-task obstacle crossing
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's enrollment of 7 is below the median of 24 across 1,566 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

Khon Kaen University is the lead sponsor of 160 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • independent ambulatory subjects with
  • traumatic causes or non-progressive diseases
  • sub-acute and chronic stage of injury (at least 3 month after injury)
  • body mass index (BMI) between 18.5-29.9 kg/m2
  • walk independently for at least 17 meters with or without assistive devices (Functional Independence Measure Locomotor (FIM-L) scores 5-7)
  • able to read Thai

Exclusion criteria

Exclusion Criteria:

  • pain in the musculoskeletal system with a pain scale more than 5 out of 10 on a the visual analog scale (VAS)
  • deformity in the joints that affect ambulatory ability
  • unable to understand the commands and tests used in the study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
7 participants (actual)

Study arms

  • Experimental
    Dual-task obstacle crossing training

    The four obstacles in the sizes of 4cm wide, 8cm wide, 4cm high, and 8cm high are randomly placed along a 10-meter walkway in 2-meter intervals. Subjects are instructed to walk continuously over obstacles at their comfortable speed, as good as they can without contact the obstacles by their leg or device. During walk over obstacles, subjects asked to perform simultaneously with a color word stroop task which requires subjects to see and answer the color of the name of a color words in the monitor (ignore the meaning) as quickly as possible, and loudly.

    Other: Dual-task obstacle crossing training

  • Sham comparator
    Single-task obstacle crossing training

    The four obstacles in the sizes of 4cm wide, 8cm wide, 4cm high, and 8cm high are randomly placed along a 10-meter walkway in 2-meter intervals. Subjects are asked to walk continuously over obstacles at their comfortable speed, as good as they can without contact the obstacles by their leg or device.

    Other: Single-task obstacle crossing training

Interventions

  • OtherDual-task obstacle crossing training

    Obstacle crossing simultaneously a color word stroop task training

  • OtherSingle-task obstacle crossing training

    Obstacle crossing training

06

What researchers measure

Primary outcomes

  1. 10MWT (Single-task)

    Walking speed in single-task condition

    Time frame: 1 day

Secondary outcomes

  1. 10MWT (Dual-task)

    Walking speed in dual-task condition

    Time frame: 1 day

  2. TUGT

    Balance ability

    Time frame: 1 day

  3. FTSST

    Lower extremity muscle strength

    Time frame: 1 day

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 28, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02917590
Lead sponsor
Khon Kaen University
Responsible party
Sugalya Amatachaya (Assoc. Prof. Dr, Khon Kaen University) — Principal investigator
First posted
Sep 28, 2016
Start date
Oct 2015
Primary completion
Feb 2017 (estimated)
Completion
Jul 2017 (estimated)
Last update
Sep 28, 2016

Study contacts

Sugalya Amatachaya, PhD
principal investigator · School of Physical Therapy, Faculty of Associated Medical Sciences, Khon Kaen University, Thailand

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion